Table 1.
Antibiotics | Hla | PVL | TSST-1 | PSM | SPA | Coagulase | Enterotoxins A and B | References |
---|---|---|---|---|---|---|---|---|
Penicillin | N | N | N | N | ↑ | N | N | [10] |
Methicillin | ↑ | N | N | N | – | – | N | [34], [35] |
Oxacillin | N | ↑ | N | ↓ | ↑ | N | N | [10] |
Nafcillin | ↑ | ↑ | N | N | N | N | N | [2], [10] |
Imipenem | N | ↑ | N | N | N | N | N | [10] |
Gentamicin | N | N | ↓ | N | N | N | N | [10] |
Erythromycin | ↓ | N | N | ↑ | N | N | N | [10] |
Flucloxacillin | N | N | ↓ | N | N | N | N | [10] |
Roxithromycin | N | N | N | N | N | ↓ | N | [35] |
Enoxacin | ↓ | N | N | N | – | – | N | [35], [34] |
Ciprofloxacin | ↓ | N | N | N | – | – | N | [35] |
Azithromycin | ↓ | N | N | N | N | N | N | [36] |
Lincomycin | N | N | N | N | N | ↓ | N | [34] |
Clindamycin | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | N | [10], [34], [36], [37] |
Fosfomycin (FOM) | ↓ | N | N | N | N | N | N | [38] |
Tigecycline | ↓ | ↓ | ↓ | N | ↓ | N | N | [10], [39] |
Vancomycin | N | – | – | N | – | N | N | [39] |
Daptomycin | N | – | N | N | – | N | N | [39] |
Linezolid | ↓ | ↓ | ↓ | ↑ | ↓ | N | ↓ | [10], [39] |
Tedizolid | ↓ | ↓ | ↓ | ↓ | N | N | N | [2] |
Mupirocin | ↓ | N | N | N | N | N | N | [37] |
Costus oil | ↓ | N | ↓ | N | N | N | N | [21] |
Fusidic acid | ↓ | N | N | N | N | N | N | [40] |
C10OOc12O | ↓ | N | N | N | N | N | N | [26] |
LP5 | ↓ | N | N | N | ↑ | N | ↓ | [41] |
Thymol | ↓ | N | N | N | N | N | ↓ | [21] |
Chlorogenic Acid | ↓ | N | N | N | N | ↓ | N | [21] |
Sclareol | ↓ | N | N | N | N | N | N | [42] |
L-NPDNJ | ↓ | N | N | N | N | N | N | [43] |
“↑”, the expression level increased; “↓”, the expression level decreased; “-”, comparable in the expression level; N, not determined.